These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 35337642)
21. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial. Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502 [TBL] [Abstract][Full Text] [Related]
22. Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma. Kirkland SW; Cross E; Campbell S; Villa-Roel C; Rowe BH Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012629. PubMed ID: 29859017 [TBL] [Abstract][Full Text] [Related]
23. Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study. Li Y; Meng Q; Rao X; Wang B; Zhang X; Dong F; Yu T; Li Z; Feng H; Zhang J; Chen X; Li H; Cheng Y; Hong X; Wang X; Yin Y; Zhang Z; Wang D Crit Care; 2020 Dec; 24(1):698. PubMed ID: 33339536 [TBL] [Abstract][Full Text] [Related]
24. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study. Torres A; Motos A; Cillóniz C; Ceccato A; Fernández-Barat L; Gabarrús A; Bermejo-Martin J; Ferrer R; Riera J; Pérez-Arnal R; García-Gasulla D; Peñuelas O; Lorente JÁ; de Gonzalo-Calvo D; Almansa R; Menéndez R; Palomeque A; Villar RA; Añón JM; Balan Mariño A; Barberà C; Barberán J; Blandino Ortiz A; Boado MV; Bustamante-Munguira E; Caballero J; Cantón-Bulnes ML; Carbajales Pérez C; Carbonell N; Catalán-González M; de Frutos R; Franco N; Galbán C; Gumucio-Sanguino VD; de la Torre MDC; Díaz E; Estella Á; Gallego E; García Garmendia JL; Gómez JM; Huerta A; García RNJ; Loza-Vázquez A; Marin-Corral J; Martin Delgado MC; Martínez de la Gándara A; Martínez Varela I; López Messa J; Albaiceta GM; Nieto M; Novo MA; Peñasco Y; Pérez-García F; Pozo-Laderas JC; Ricart P; Sagredo V; Sánchez-Miralles A; Sancho Chinesta S; Serra-Fortuny M; Socias L; Solé-Violan J; Suarez-Sipmann F; Tamayo Lomas L; Trenado J; Úbeda A; Valdivia LJ; Vidal P; Barbé F; Intensive Care Med; 2022 Jul; 48(7):850-864. PubMed ID: 35727348 [TBL] [Abstract][Full Text] [Related]
25. Anakinra or high-dose corticosteroids in COVID-19 pneumonia patients who deteriorate on low-dose dexamethasone: an observational study of comparative effectiveness. Langer-Gould A; Xu S; Myers LC; Chen A; Greene JD; Creekmur B; Bruxvoort K; Adams JL; Liu V; Gould MK Int J Infect Dis; 2023 Jan; 126():87-93. PubMed ID: 36403818 [TBL] [Abstract][Full Text] [Related]
26. The proportion and effect of corticosteroid therapy in patients with COVID-19 infection: A systematic review and meta-analysis. Wang J; Yang W; Chen P; Guo J; Liu R; Wen P; Li K; Lu Y; Ma T; Li X; Qin S; Zhang Y; Wang Y PLoS One; 2021; 16(4):e0249481. PubMed ID: 33882090 [TBL] [Abstract][Full Text] [Related]
27. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT. Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402 [TBL] [Abstract][Full Text] [Related]
28. The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness. Delaney JW; Pinto R; Long J; Lamontagne F; Adhikari NK; Kumar A; Marshall JC; Cook DJ; Jouvet P; Ferguson ND; Griesdale D; Burry LD; Burns KE; Hutchison J; Mehta S; Menon K; Fowler RA; Crit Care; 2016 Mar; 20():75. PubMed ID: 27036638 [TBL] [Abstract][Full Text] [Related]
29. Timing of corticosteroids impacts mortality in hospitalized COVID-19 patients. Bahl A; Johnson S; Chen NW Intern Emerg Med; 2021 Sep; 16(6):1593-1603. PubMed ID: 33547620 [TBL] [Abstract][Full Text] [Related]
30. Do high-dose corticosteroids improve outcomes in hospitalized COVID-19 patients? Kumar G; Patel D; Hererra M; Jefferies D; Sakhuja A; Meersman M; Dalton D; Nanchal R; Guddati AK J Med Virol; 2022 Jan; 94(1):372-379. PubMed ID: 34559436 [TBL] [Abstract][Full Text] [Related]
31. Antenatal corticosteroids for pregnant women with COVID-19 infection and preterm prelabor rupture of membranes: a decision analysis. Zhou CG; Packer CH; Hersh AR; Caughey AB J Matern Fetal Neonatal Med; 2022 May; 35(9):1643-1651. PubMed ID: 32429722 [TBL] [Abstract][Full Text] [Related]
32. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
33. Implementation of an antenatal late-preterm corticosteroid protocol at a high-volume tertiary care center. Badreldin N; Willert GG; Henricks AA; Peaceman A; Caldarelli LA; Yee LM Am J Obstet Gynecol MFM; 2020 Feb; 2(1):100076. PubMed ID: 32944712 [TBL] [Abstract][Full Text] [Related]
34. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study. Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796 [TBL] [Abstract][Full Text] [Related]
35. Role of systemic corticosteroids in preventing hypoxia among patients with mild COVID-19: An observational study. Aggarwal A; Mittal A; Soneja M; Shankar SH; Naik S; Kodan P; Nischal N; Jorwal P; Ray A; Wig N Drug Discov Ther; 2021 Nov; 15(5):273-277. PubMed ID: 34707019 [TBL] [Abstract][Full Text] [Related]
36. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial. Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638 [TBL] [Abstract][Full Text] [Related]
37. Corticosteroids showed more efficacy in treating hospitalized patients with COVID-19 than standard care but the effect is minimal: A systematic review and meta-analysis. Liu J; Dong J; Yu Y; Yang X; Shu J; Bao H Front Public Health; 2022; 10():847695. PubMed ID: 35937252 [TBL] [Abstract][Full Text] [Related]
38. Corticosteroids in critical COVID-19: Are all corticosteroids equal? Du Plessis EM; Lalla U; Allwood BW; Louw EH; Nortje A; Parker A; Taljaard JJ; Ayele BT; Nyasulu PS; Koegelenberg CFN S Afr Med J; 2021 Apr; 111(6):550-553. PubMed ID: 34382564 [TBL] [Abstract][Full Text] [Related]
39. Corticosteroids as adjunctive therapy in the treatment of influenza. Lansbury L; Rodrigo C; Leonardi-Bee J; Nguyen-Van-Tam J; Lim WS Cochrane Database Syst Rev; 2019 Feb; 2(2):CD010406. PubMed ID: 30798570 [TBL] [Abstract][Full Text] [Related]